Literature DB >> 33597676

Spatial immune profiling of the colorectal tumor microenvironment predicts good outcome in stage II patients.

Ines P Nearchou1, Bethany M Gwyther2, Elena C T Georgiakakis2, Christos G Gavriel2, Kate Lillard3, Yoshiki Kajiwara4, Hideki Ueno4, David J Harrison2,5, Peter D Caie2.   

Abstract

Cellular subpopulations within the colorectal tumor microenvironment (TME) include CD3+ and CD8+ lymphocytes, CD68+ and CD163+ macrophages, and tumor buds (TBs), all of which have known prognostic significance in stage II colorectal cancer. However, the prognostic relevance of their spatial interactions remains unknown. Here, by applying automated image analysis and machine learning approaches, we evaluate the prognostic significance of these cellular subpopulations and their spatial interactions. Resultant data, from a training cohort retrospectively collated from Edinburgh, UK hospitals (n = 113), were used to create a combinatorial prognostic model, which identified a subpopulation of patients who exhibit 100% survival over a 5-year follow-up period. The combinatorial model integrated lymphocytic infiltration, the number of lymphocytes within 50-μm proximity to TBs, and the CD68+/CD163+ macrophage ratio. This finding was confirmed on an independent validation cohort, which included patients treated in Japan and Scotland (n = 117). This work shows that by analyzing multiple cellular subpopulations from the complex TME, it is possible to identify patients for whom surgical resection alone may be curative.

Year:  2020        PMID: 33597676     DOI: 10.1038/s41746-020-0275-x

Source DB:  PubMed          Journal:  NPJ Digit Med        ISSN: 2398-6352


  32 in total

1.  Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  R Labianca; B Nordlinger; G D Beretta; S Mosconi; M Mandalà; A Cervantes; D Arnold
Journal:  Ann Oncol       Date:  2013-10       Impact factor: 32.976

2.  Tumour budding in colorectal cancer: molecular rationale for clinical translation.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

3.  Prognostic Impact of Tumor-Infiltrating Lymphocytes in Primary and Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.

Authors:  Joseph C Kong; Glen R Guerra; Toan Pham; Catherine Mitchell; A Craig Lynch; Satish K Warrier; Robert G Ramsay; Alexander G Heriot
Journal:  Dis Colon Rectum       Date:  2019-04       Impact factor: 4.585

4.  Automated Analysis of Lymphocytic Infiltration, Tumor Budding, and Their Spatial Relationship Improves Prognostic Accuracy in Colorectal Cancer.

Authors:  Ines P Nearchou; Kate Lillard; Christos G Gavriel; Hideki Ueno; David J Harrison; Peter D Caie
Journal:  Cancer Immunol Res       Date:  2019-03-07       Impact factor: 11.151

5.  Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study.

Authors:  Viktor H Koelzer; Inti Zlobec; Martin D Berger; Gieri Cathomas; Heather Dawson; Klaus Dirschmid; Marion Hädrich; Daniel Inderbitzin; Felix Offner; Giacomo Puppa; Walter Seelentag; Beat Schnüriger; Luigi Tornillo; Alessandro Lugli
Journal:  Virchows Arch       Date:  2015-02-21       Impact factor: 4.064

6.  Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

Authors:  H Ueno; J Murphy; J R Jass; H Mochizuki; I C Talbot
Journal:  Histopathology       Date:  2002-02       Impact factor: 5.087

Review 7.  Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

Authors:  Alessandro Lugli; Richard Kirsch; Yoichi Ajioka; Fred Bosman; Gieri Cathomas; Heather Dawson; Hala El Zimaity; Jean-François Fléjou; Tine Plato Hansen; Arndt Hartmann; Sanjay Kakar; Cord Langner; Iris Nagtegaal; Giacomo Puppa; Robert Riddell; Ari Ristimäki; Kieran Sheahan; Thomas Smyrk; Kenichi Sugihara; Benoît Terris; Hideki Ueno; Michael Vieth; Inti Zlobec; Phil Quirke
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

8.  International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

Authors:  Franck Pagès; Bernhard Mlecnik; Florence Marliot; Gabriela Bindea; Fang-Shu Ou; Carlo Bifulco; Alessandro Lugli; Inti Zlobec; Tilman T Rau; Martin D Berger; Iris D Nagtegaal; Elisa Vink-Börger; Arndt Hartmann; Carol Geppert; Julie Kolwelter; Susanne Merkel; Robert Grützmann; Marc Van den Eynde; Anne Jouret-Mourin; Alex Kartheuser; Daniel Léonard; Christophe Remue; Julia Y Wang; Prashant Bavi; Michael H A Roehrl; Pamela S Ohashi; Linh T Nguyen; SeongJun Han; Heather L MacGregor; Sara Hafezi-Bakhtiari; Bradly G Wouters; Giuseppe V Masucci; Emilia K Andersson; Eva Zavadova; Michal Vocka; Jan Spacek; Lubos Petruzelka; Bohuslav Konopasek; Pavel Dundr; Helena Skalova; Kristyna Nemejcova; Gerardo Botti; Fabiana Tatangelo; Paolo Delrio; Gennaro Ciliberto; Michele Maio; Luigi Laghi; Fabio Grizzi; Tessa Fredriksen; Bénédicte Buttard; Mihaela Angelova; Angela Vasaturo; Pauline Maby; Sarah E Church; Helen K Angell; Lucie Lafontaine; Daniela Bruni; Carine El Sissy; Nacilla Haicheur; Amos Kirilovsky; Anne Berger; Christine Lagorce; Jeffrey P Meyers; Christopher Paustian; Zipei Feng; Carmen Ballesteros-Merino; Jeroen Dijkstra; Carlijn van de Water; Shannon van Lent-van Vliet; Nikki Knijn; Ana-Maria Mușină; Dragos-Viorel Scripcariu; Boryana Popivanova; Mingli Xu; Tomonobu Fujita; Shoichi Hazama; Nobuaki Suzuki; Hiroaki Nagano; Kiyotaka Okuno; Toshihiko Torigoe; Noriyuki Sato; Tomohisa Furuhata; Ichiro Takemasa; Kyogo Itoh; Prabhu S Patel; Hemangini H Vora; Birva Shah; Jayendrakumar B Patel; Kruti N Rajvik; Shashank J Pandya; Shilin N Shukla; Yili Wang; Guanjun Zhang; Yutaka Kawakami; Francesco M Marincola; Paolo A Ascierto; Daniel J Sargent; Bernard A Fox; Jérôme Galon
Journal:  Lancet       Date:  2018-05-10       Impact factor: 79.321

9.  Clinicopathological significance and prognostic role of tumor-infiltrating lymphocytes in colorectal cancer.

Authors:  Young San Ko; Jung-Soo Pyo
Journal:  Int J Biol Markers       Date:  2019-03-11       Impact factor: 2.659

Review 10.  Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

Authors:  Jérôme Galon; Bernhard Mlecnik; Gabriela Bindea; Helen K Angell; Anne Berger; Christine Lagorce; Alessandro Lugli; Inti Zlobec; Arndt Hartmann; Carlo Bifulco; Iris D Nagtegaal; Richard Palmqvist; Giuseppe V Masucci; Gerardo Botti; Fabiana Tatangelo; Paolo Delrio; Michele Maio; Luigi Laghi; Fabio Grizzi; Martin Asslaber; Corrado D'Arrigo; Fernando Vidal-Vanaclocha; Eva Zavadova; Lotfi Chouchane; Pamela S Ohashi; Sara Hafezi-Bakhtiari; Bradly G Wouters; Michael Roehrl; Linh Nguyen; Yutaka Kawakami; Shoichi Hazama; Kiyotaka Okuno; Shuji Ogino; Peter Gibbs; Paul Waring; Noriyuki Sato; Toshihiko Torigoe; Kyogo Itoh; Prabhu S Patel; Shilin N Shukla; Yili Wang; Scott Kopetz; Frank A Sinicrope; Viorel Scripcariu; Paolo A Ascierto; Francesco M Marincola; Bernard A Fox; Franck Pagès
Journal:  J Pathol       Date:  2014-01       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.